The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world comparison: Neoadjuvant pembrolizumab (pembro-NACT) vs. dose-dense neoadjuvant chemotherapy (ddNACT) in early stage triple-negative breast cancer (TNBC).
 
Mali Barbi
No Relationships to Disclose
 
Jovanka Noel
No Relationships to Disclose
 
Chung-Shien Lee
No Relationships to Disclose
 
Husneara Rahman
No Relationships to Disclose
 
Kit Cheng
Honoraria - bioTheranostics; GlaxoSmithKline